Skip to content
10-K

Annual Report

Entia Biosciences, Inc.

0001185185-17-001225

← back to feed
Filed
May 19, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2016 · May 19, 2017 33.66M sh
Capex FY 2016 · Dec 31, 2016 $0
Capex FY 2016 · Dec 31, 2015 $8.05K
Operating Cash Flow FY 2016 · Dec 31, 2016 −$715.1K
Operating Cash Flow FY 2016 · Dec 31, 2015 −$536.57K
Short Term Debt FY 2016 · Dec 31, 2016 $10K
Short Term Debt FY 2016 · Dec 31, 2015 $0
Cash And Equivalents FY 2016 · Dec 31, 2016 $76.05K
Cash And Equivalents FY 2016 · Dec 31, 2015 $24.13K
Cash And Equivalents FY 2016 · Dec 31, 2014 $99.46K
Stockholders Equity FY 2016 · Dec 31, 2016 −$1.97M
Stockholders Equity FY 2016 · Dec 31, 2015 −$791.19K
Stockholders Equity FY 2016 · Dec 31, 2014 −$116.54K
Current Liabilities FY 2016 · Dec 31, 2016 $2.11M
Current Liabilities FY 2016 · Dec 31, 2015 $1.24M
Total Liabilities FY 2016 · Dec 31, 2016 $2.41M
Total Liabilities FY 2016 · Dec 31, 2015 $1.24M
Current Assets FY 2016 · Dec 31, 2016 $234.35K
Current Assets FY 2016 · Dec 31, 2015 $128.34K
Total Assets FY 2016 · Dec 31, 2016 $439.14K
Total Assets FY 2016 · Dec 31, 2015 $448.61K
Sga Expense FY 2016 · Dec 31, 2016 $960.04K
Sga Expense FY 2016 · Dec 31, 2015 $1.43M
Rd Expense FY 2016 · Dec 31, 2016 $37.75K
Rd Expense FY 2016 · Dec 31, 2015 $73.39K
Net Income FY 2016 · Dec 31, 2016 −$1.4M
Net Income FY 2016 · Dec 31, 2015 −$2.26M
Operating Income FY 2016 · Dec 31, 2016 −$1.31M
Operating Income FY 2016 · Dec 31, 2015 −$2.03M
Gross Profit FY 2016 · Dec 31, 2016 $173.97K
Gross Profit FY 2016 · Dec 31, 2015 $215.9K
Cost Of Revenue FY 2016 · Dec 31, 2016 $91.5K
Cost Of Revenue FY 2016 · Dec 31, 2015 $131.01K
Revenue FY 2016 · Dec 31, 2016 $265.47K
Revenue FY 2016 · Dec 31, 2015 $346.91K